Prescription drug pricing Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Prescription Drug Rebate Issues Tax Reform Implementation Issues TRICARE Policy Issues including Telehealth and Value-Based Care NDAA Implementation Policy Issues Veterans Healthcare and Policy Issues H.R. 2670, National Defense Authorization Act for Fiscal Year 2024 S. 2226, National Defense Authorization Act for Fiscal Year 2024 Medicare Advantage (MA) Policy and Reimbursement Announcement of Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) Medicare Part D Issues Medicaid Policy Issues Including Redeterminations and Dual Eligibles Pharmacy Benefit Managers (PBM) and Pharmacy Policy and Reimbursement Issues Home Health Policy and Reimbursement Issues Prescription Drug Rebate Issues Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act (117th Congress) Prior Authorization Policy and Regulatory Issues Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (RIN 0955-AA03) CMS Guidance on Direct Negotiation (Official Title: Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2026, and Solicitation of Comments) CMS-4185-F2 Medicare Advantage Risk Adjustment Data Validation Final Rule Primary Care and Value-Based Care Policy and Reimbursement Clinical Policy Issues Including Workforce and Mental Health CY 2024 Home Health Prospective Payment System Proposed Rule (CMS-1780-P) FY 2024 Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Proposed Rule (CMS-1785-P) CY 2024 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS 1786-P) CY 2024 Medicare Physician Fee Schedule Proposed Rule (CMS-1784-P) Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022 Proposed Rule (CMS 1793-P) H.R. 4822, Health Care Price Transparency Act of 2023 Implementation of Inflation Reduction Act of 2022 Public Law No. 117-169 CMS-0057-P Interoperability and Prior Authorization Proposed Rule Clinical Policy Issues Including Workforce and Mental Health Employer Group Coverage Policy Issues
PHA - Pharmacy TAX - Taxation/Internal Revenue Code DEF - Defense MMM - Medicare/Medicaid HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 12 - White House Office 25 - Defense, Dept of (DOD) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 42 - Veterans Affairs, Dept of (VA) 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 12 - White House Office
HUMANA, INC.
500 WEST MAIN STREET, LOUISVILLE, KY, 40202, US
JEFFREY LUNGREN VERONICA JACKSON RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON VERONICA JACKSON JEFFREY LUNGREN RACHEL MAGNUSON